Increasing evidence suggests hypophysitis may be associated with immunotherapy (interleukin 2, interferon) and medications targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) or programmed cell death 1 (PD-1) [6]. Here, CTLA4 is linked to hypophysitis.